The Industry, Philanthropy and Commercialisation Committee provides strategic advice on health and medical research, and health issues through an industry and philanthropic scope.
The NHMRC-MRFF Industry, Philanthropy and Commercialisation Committee will advise the NHMRC and NHMRC Chief Executive Officer (CEO) and/or the Australian Medical Research Advisory Board (AMRAB) and CEO of the Australian Department of Health and Aged Care’s Health and Medical Research Office (HMRO) on:
- Strategies to foster the translation of research into clinical and commercial outcomes to improve the health and wellbeing of the Australian community
- Opportunities to connect to, build and coordinate financial support and co-investment for health and medical research, including through the participation of Australia’s industry and philanthropic sectors
- Strategies for fostering of an innovation and evidence-based culture within Australia’s research workforce, including within industry and the health system
- Any other matter referred to it by the NHMRC CEO and/or HMRO CEO.
Membership
The joint National Health and Medical Research (NHMRC)-Medical Research Future Fund (MRFF) Industry, Philanthropy and Commercialisation Committee is established as a working committee under Section 39 of the NHMRC Act 1992. The committee members for the 2024-2027 triennium are below.
Committee members
Chair,
Ms
Bronwyn
Le Grice
Chief Executive Officer and Managing Director, ANDHealth
Bronwyn has over 20 years executive experience in health technology commercialisation, investment and industry advocacy. She is the CEO and Founder of ANDHealth, an organisation that supports digital and connected health companies in Australia by providing guidance, resources, non-dilutive funding and mentorship to help them navigate the complexities of commercialisation in the healthcare industry and successfully takes innovative technologies to the Australian and global markets. Bronwyn has a Masters of Commercial Law (UniMelb) and a Bachelor of Commerce (UWA) and is passionate about driving innovation in health and care through technology. Under her leadership, ANDHealth has played a significant role in fostering the growth of digital health and connected health technologies and promoting innovation in the Australian healthcare landscape.
Dr
Noel
Chambers
Chief Executive Officer, National Foundation for Medical Research and Innovation
Ms
Elizabeth
de Somer
Chief Executive Officer, Medicines Australia
Professor
Matt
Dun
Professor of Biomedical Sciences, University of Newcastle
Associate Professor
Tuguy
Esgin
Dean of Indigenous Engagement in the Faculty of Business & Law, Curtin University
Associate Professor
Jiawen
Li
Associate Professor in the School of Electrical and Mechanical Engineering, University of Adelaide
Professor
Fabienne
Mackay
Chief Executive Officer and Director, QIMR Berghofer Medical Research Institute
Dr
Dean
Moss
Chief Executive Officer, UniQuest (UQ Commercialisation Entity)
Dr
Chris
Nave
Founding Partner and Managing Director, Brandon Capital/BioCatalyst
Dr
Jeanette
Pritchard
Chief Executive Officer, Passe & Williams Foundation (Philanthropic Org)
Professor
Karen
Reynolds
Dean of the Medical Device Research Institute, Flinders University
Ms
Kylie
Sproston
Chief Executive Officer, Bellberry Ltd
Mr
Mark
Sullivan
AO
Chief Executive Officer and Managing Director, Medicines Development for Global Health
Professor
Andrew
Wilks
Chief Executive Officer, SYNthesis Research/ Catalyst Tx